Arrowstreet Capital Limited Partnership Purchases 43,864 Shares of Maximus, Inc. (NYSE:MMS)

Arrowstreet Capital Limited Partnership boosted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 108.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 84,309 shares of the health services provider's stock after purchasing an additional 43,864 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.15% of Maximus worth $6,294,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nordea Investment Management AB acquired a new stake in shares of Maximus during the fourth quarter worth approximately $4,618,000. Fort Washington Investment Advisors Inc. OH boosted its stake in Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after purchasing an additional 83,390 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Maximus in the fourth quarter valued at $1,113,000. Finally, Legato Capital Management LLC raised its holdings in shares of Maximus by 33.9% in the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after buying an additional 8,138 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

MMS has been the subject of several research reports. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd.

Insider Transactions at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Maximus Trading Up 1.4 %

Shares of NYSE MMS traded up $0.94 during midday trading on Friday, hitting $68.41. The stock had a trading volume of 527,898 shares, compared to its average volume of 548,296. The firm has a market cap of $3.87 billion, a P/E ratio of 14.71 and a beta of 0.68. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company's 50-day simple moving average is $67.90 and its 200 day simple moving average is $76.15.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's payout ratio is 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.